Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96M
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
50.8M
-
Shares change
-
-235K
-
Total reported value, excl. options
-
$380M
-
Value change
-
-$32.1M
-
Put/Call ratio
-
2.2
-
Number of buys
-
70
-
Number of sells
-
-83
-
Price
-
$7.48
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q2 2024
180 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q2 2024.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.8M shares
of 96M outstanding shares and own 52.91% of the company stock.
Largest 10 shareholders include JENNISON ASSOCIATES LLC (5.55M shares), BlackRock Inc. (4.76M shares), T. Rowe Price Investment Management, Inc. (3.88M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.04M shares), ALKEON CAPITAL MANAGEMENT LLC (2.62M shares), FRED ALGER MANAGEMENT, LLC (2.52M shares), VANGUARD GROUP INC (2.37M shares), STATE STREET CORP (2.01M shares), Bain Capital Life Sciences Investors, LLC (1.65M shares), and VR Adviser, LLC (1.56M shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.